Joel Greenblatt Meridian Bioscience Inc Transaction History

Gotham Asset Management, LLC

$7.56 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$31.15 - $33.39 $369,127 - $395,671	-11,850 Reduced 54.09%	10,058 $334,000
Q3 2022 Nov 14, 2022	BUY	$30.9 - $33.55 $676,957 - $735,013	21,908 New	21,908 $691,000
Q3 2021 Nov 15, 2021	SELL	$17.35 - $22.5 $662,423 - $859,050	-38,180 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.01 - $28.32 $249,312 - $392,033	13,843 Added 56.88%	38,180 $847,000
Q1 2021 May 17, 2021	SELL	$19.76 - $29.89 $162,960 - $246,502	-8,247 Reduced 25.31%	24,337 $639,000
Q4 2020 Feb 16, 2021	BUY	$15.73 - $21.66 $316,188 - $435,387	20,101 Added 161.03%	32,584 $609,000
Q3 2020 Nov 16, 2020	BUY	$13.54 - $26.41 $10,100 - $19,701	746 Added 6.36%	12,483 $212,000
Q2 2020 Aug 13, 2020	SELL	$7.84 - $23.29 $16,432 - $48,815	-2,096 Reduced 15.15%	11,737 $273,000
Q1 2020 May 15, 2020	BUY	$5.57 - $11.5 $77,049 - $159,079	13,833 New	13,833 $116,000
Q4 2019 Feb 14, 2020	SELL	$7.9 - $10.14 $161,460 - $207,241	-20,438 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$9.17 - $12.01 $109,260 - $143,099	-11,915 Reduced 36.83%	20,438 $194,000
Q2 2019 Aug 14, 2019	SELL	$10.88 - $17.6 $9,900 - $16,016	-910 Reduced 2.74%	32,353 $384,000
Q1 2019 May 15, 2019	BUY	$15.51 - $17.61 $240,637 - $273,219	15,515 Added 87.42%	33,263 $586,000
Q4 2018 Feb 14, 2019	SELL	$14.52 - $19.72 $94,931 - $128,929	-6,538 Reduced 26.92%	17,748 $308,000
Q3 2018 Nov 14, 2018	SELL	$14.85 - $16.35 $31,288 - $34,449	-2,107 Reduced 7.98%	24,286 $362,000
Q2 2018 Aug 14, 2018	SELL	$13.8 - $16.8 $206,185 - $251,008	-14,941 Reduced 36.15%	26,393 $420,000
Q1 2018 May 15, 2018	SELL	$13.8 - $16.2 $1.64 Million - $1.92 Million	-118,582 Reduced 74.15%	41,334 $587,000
Q4 2017 Feb 14, 2018	SELL	$13.55 - $15.8 $491,837 - $573,508	-36,298 Reduced 18.5%	159,916 $2.24 Million
Q3 2017 Nov 14, 2017	BUY	$13.45 - $14.35 $2.64 Million - $2.82 Million	196,214	196,214 $2.81 Million

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account